"Morinaga Ramune" Records All-Time High Sales, Boosted by Glucose Demand
⚡ What Happened
Morinaga & Co.'s long-selling product "Morinaga Ramune" achieved all-time high sales. The key driver was the explosive growth in adult demand, as the candy's defining feature — glucose as its main ingredient — was reappraised as a tool for "improving concentration" and a "work companion." Going forward, accelerated development of derivative products and collaborations is expected, but sustainability after the boom cycle runs its course remains a challenge.
Morinaga Ramune has long been a beloved long-seller, but in recent years, word-of-mouth claims that "its main ingredient, glucose, boosts concentration" spread primarily through social media, triggering an explosive reappraisal among business professionals and exam students. Morinaga & Co. seized on this trend by expanding its adult-oriented lineup, including large-grain types and bottled versions. Placement near convenience store registers also proved effective. At its core, this represents the rise of the "functional snack" category, sharing the same context as the rapid growth of the gummy market. As Japan's confectionery market matures, growth through the redefinition of existing brands is becoming a strategic model for the entire industry. Achieving record-high sales amid rising raw material costs and labor shortages is evidence that both price pass-throughs and volume increases are working in tandem.
🔍 For Morinaga & Co., the success of Ramune serves as a lifeline while its core chocolate business faces profit pressure from soaring cacao prices. The profit contribution of low-cost Ramune-type products is far greater than the numbers alone suggest. Moreover, the marketing strategy of foregrounding "health and functionality" to reduce snacking guilt cleverly exploits the gap between perception and actual scientific evidence. Some research suggests that the concentration-boosting effects of glucose are limited, and the company itself is surely aware of the risk of a post-boom backlash.
📰 Source: Yahoo
🧭 Why This Is Moving Now
domain=economics
🔮 Next Scenarios
🎯 Incentive Map
| Player | True Incentive | Underlying Vulnerability | Predicted Action |
|---|---|---|---|
| Morinaga & Co. | With cacao price surges squeezing chocolate business profits, the company wants to maximize its high-margin Ramune business and stabilize portfolio earnings | An urgency to break free from core chocolate dependency. While aware of the risk of over-reliance on Ramune's success, short-term earnings pressure tends to concentrate investment there | Mass launch of Ramune derivative products, strengthened adult-targeted marketing, and consideration of applying for Foods with Function Claims certification |
| Convenience Store Chains | Prioritize Ramune as a high-turnover, high-margin product near registers. Also entering the glucose tablet market with private-label products, aiming to expand the overall category while maximizing own profits | Rigidity in existing shelf allocation. Dedicating too much shelf space to trending products creates an opportunity cost dilemma for staple items | Expand shelf space for glucose products across both national and private-label brands, but quickly scale back at the first signs of the boom fading |
| Competing Confectionery Makers (UHA Mikakuto, Kanro, etc.) | Leverage their success in the gummy market to launch competing products in the functional snack category and capture market share | As latecomers against an established category leader in Ramune, differentiation is difficult. Risk of falling into price competition | Launch competing products built around proprietary functional claims (GABA, L-theanine, etc.) to grow the overall category while capturing share |
⚠️ Pre-Mortem — Conditions Under Which This Prediction Fails
- The functional snack trend persists longer than expected, adult demand does not saturate, and year-over-year growth is achieved (historically, roughly half of food brands that hit record highs continue growing the following year)
- Morinaga significantly expands the Ramune brand into international markets or new channels such as e-commerce and subscriptions, achieving structural change that more than compensates for domestic deceleration
- The possibility that we are being influenced by a mean-reversion bias of "growth slows after record highs." Glucose demand may not be a passing fad but rather supported by structural changes such as work-style reforms and the entrenchment of remote work
Hit Condition: HIT if Morinaga & Co. reports a year-over-year decline in Ramune-related sales in its FY2026 (fiscal year ending March 2027) financial results
Resolution Date: 2027-03-31
